Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armon, C.
Right arrow Articles by Kurland, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armon, C.
Right arrow Articles by Kurland, L. T.
NEUROLOGY 1990;40:172
© 1990 American Academy of Neurology

How frequently does classic amyotrophic lateral sclerosis develop in survivors of poliomyelitis?

Carmel Armon, MD, Jasper R. Daube, MD, Anthony J. Windebank, MD and Leonard T. Kurland, MD, DrPH

Department of Neurology (Drs. Armon, Daube, and Windebank), and the Section of Clinical Epidemiology (Dr. Kurland), Mayo Clinic and Mayo Foundation, Rochester, MN.

There is a paucity of reports of classic amyotrophic lateral sclerosis (ALS) developing in survivors of paralytic poliomyelitis. We describe a patient with classic ALS and an antecedent paralytic disease thought to have been poliomyelitis from which she recovered completely. If the paucity of ALS preceded by true poliomyelitis is not merely a matter of underreporting, antecedent paralytic poliomyelitis may have a protective role against the development of ALS. This has implications relevant to pathogenesis and to projected secular trends of ALS incidence since the introduction of poliomyelitis vaccines. There is a need to establish the incidence of cases of classic ALS in patients with antecedent poliomyelitis.

Address correspondence and reprint requests to Dr. Jasper R. Daube, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Supported in part by a grant from the Easter Seal Research Foundation and by Neuroepidemiologic Program Project Grant NS 17750 from NINCDS.

Received May 9, 1989. Accepted for publication in final form June 28, 1989.




This article has been cited by other articles:


Home page
NeurologyHome page
B. Jubelt and H. L. Lipton
ALS: Persistent scientists do not find persisting enteroviruses
Neurology, April 27, 2004; 62(8): 1250 - 1251.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.